Cameron Durfee
Impact in
-
- HIV Research and Treatment
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Papers in
-
- RNA Research and Splicing 2
- CRISPR and Genetic Engineering 2
- Extracellular vesicles in disease 1
- Genomics and Chromatin Dynamics 1
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Hideki Aihara (2 shared papers)Rommie E. Amaro (1 shared paper)Özlem Demir (1 shared paper)Ke Shi (1 shared paper)Surajit Banerjee (1 shared paper)Lulu Yin (1 shared paper)Nuri A. Temiz (4 shared papers)Reuben S. Harris (5 shared papers)
- Journals
- The Journal of Experimental Medicine (1 paper)International Journal of Molecular Sciences (1 paper)Proceedings of the National Academy of Sciences (1 paper)Diabetes (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Cameron Durfee
6 papers receiving 225 citations
Peers
Comparison fields: 5 of 45
- Virology 28
- Infectious Diseases 86
- Cancer Research 40
- Molecular Biology 136
- Oncology 39
Countries citing papers authored by Cameron Durfee
This map shows the geographic impact of Cameron Durfee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Durfee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Durfee more than expected).
Fields of papers citing papers by Cameron Durfee
This network shows the impact of papers produced by Cameron Durfee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Durfee. The network helps show where Cameron Durfee may publish in the future.
Co-authors
The 25 scholars most cited alongside Cameron Durfee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 85 | |
| 2 | 2020 | 83 | |
| 3 | 2023 | 24 | |
| 4 | 2024 | 18 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 8 |
About Cameron Durfee
Cameron Durfee is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 6 papers that have together received 226 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), RNA Research and Splicing (2 papers), CRISPR and Genetic Engineering (2 papers), HIV Research and Treatment (1 paper), Genetic factors in colorectal cancer (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Extracellular vesicles in disease (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Virology (28 citations), Infectious Diseases (86 citations), Cancer Research (40 citations), Molecular Biology (136 citations) and Oncology (39 citations). Cameron Durfee has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Hideki Aihara, Rommie E. Amaro, Özlem Demir, Ke Shi, Surajit Banerjee, Lulu Yin, Nuri A. Temiz, Reuben S. Harris, Prokopios P. Argyris and Rena Levin-Klein. Their work appears in journals such as The Journal of Experimental Medicine, International Journal of Molecular Sciences, Proceedings of the National Academy of Sciences, Diabetes and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.